Cargando…

Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor

Despite intense interest in designing positive allosteric modulators (PAMs) as selective drugs of the adenosine A(1) receptor (A(1)AR), structural binding modes of the receptor PAMs remain unknown. Using the first X-ray structure of the A(1)AR, we have performed all-atom simulations using a robust G...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Yinglong, Bhattarai, Apurba, Nguyen, Anh T. N., Christopoulos, Arthur, May, Lauren T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237911/
https://www.ncbi.nlm.nih.gov/pubmed/30442899
http://dx.doi.org/10.1038/s41598-018-35266-x
_version_ 1783371269560860672
author Miao, Yinglong
Bhattarai, Apurba
Nguyen, Anh T. N.
Christopoulos, Arthur
May, Lauren T.
author_facet Miao, Yinglong
Bhattarai, Apurba
Nguyen, Anh T. N.
Christopoulos, Arthur
May, Lauren T.
author_sort Miao, Yinglong
collection PubMed
description Despite intense interest in designing positive allosteric modulators (PAMs) as selective drugs of the adenosine A(1) receptor (A(1)AR), structural binding modes of the receptor PAMs remain unknown. Using the first X-ray structure of the A(1)AR, we have performed all-atom simulations using a robust Gaussian accelerated molecular dynamics (GaMD) technique to determine binding modes of the A(1)AR allosteric drug leads. Two prototypical PAMs, PD81723 and VCP171, were selected. Each PAM was initially placed at least 20 Å away from the receptor. Extensive GaMD simulations using the AMBER and NAMD simulation packages at different acceleration levels captured spontaneous binding of PAMs to the A(1)AR. The simulations allowed us to identify low-energy binding modes of the PAMs at an allosteric site formed by the receptor extracellular loop 2 (ECL2), which are highly consistent with mutagenesis experimental data. Furthermore, the PAMs stabilized agonist binding in the receptor. In the absence of PAMs at the ECL2 allosteric site, the agonist sampled a significantly larger conformational space and even dissociated from the A(1)AR alone. In summary, the GaMD simulations elucidated structural binding modes of the PAMs and provided important insights into allostery in the A(1)AR, which will greatly facilitate the receptor structure-based drug design.
format Online
Article
Text
id pubmed-6237911
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-62379112018-11-23 Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor Miao, Yinglong Bhattarai, Apurba Nguyen, Anh T. N. Christopoulos, Arthur May, Lauren T. Sci Rep Article Despite intense interest in designing positive allosteric modulators (PAMs) as selective drugs of the adenosine A(1) receptor (A(1)AR), structural binding modes of the receptor PAMs remain unknown. Using the first X-ray structure of the A(1)AR, we have performed all-atom simulations using a robust Gaussian accelerated molecular dynamics (GaMD) technique to determine binding modes of the A(1)AR allosteric drug leads. Two prototypical PAMs, PD81723 and VCP171, were selected. Each PAM was initially placed at least 20 Å away from the receptor. Extensive GaMD simulations using the AMBER and NAMD simulation packages at different acceleration levels captured spontaneous binding of PAMs to the A(1)AR. The simulations allowed us to identify low-energy binding modes of the PAMs at an allosteric site formed by the receptor extracellular loop 2 (ECL2), which are highly consistent with mutagenesis experimental data. Furthermore, the PAMs stabilized agonist binding in the receptor. In the absence of PAMs at the ECL2 allosteric site, the agonist sampled a significantly larger conformational space and even dissociated from the A(1)AR alone. In summary, the GaMD simulations elucidated structural binding modes of the PAMs and provided important insights into allostery in the A(1)AR, which will greatly facilitate the receptor structure-based drug design. Nature Publishing Group UK 2018-11-15 /pmc/articles/PMC6237911/ /pubmed/30442899 http://dx.doi.org/10.1038/s41598-018-35266-x Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Miao, Yinglong
Bhattarai, Apurba
Nguyen, Anh T. N.
Christopoulos, Arthur
May, Lauren T.
Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor
title Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor
title_full Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor
title_fullStr Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor
title_full_unstemmed Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor
title_short Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor
title_sort structural basis for binding of allosteric drug leads in the adenosine a(1) receptor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237911/
https://www.ncbi.nlm.nih.gov/pubmed/30442899
http://dx.doi.org/10.1038/s41598-018-35266-x
work_keys_str_mv AT miaoyinglong structuralbasisforbindingofallostericdrugleadsintheadenosinea1receptor
AT bhattaraiapurba structuralbasisforbindingofallostericdrugleadsintheadenosinea1receptor
AT nguyenanhtn structuralbasisforbindingofallostericdrugleadsintheadenosinea1receptor
AT christopoulosarthur structuralbasisforbindingofallostericdrugleadsintheadenosinea1receptor
AT maylaurent structuralbasisforbindingofallostericdrugleadsintheadenosinea1receptor